npc 17761 has been researched along with arg-3-hyp-7-phe-bradykinin in 1 studies
| Studies (npc 17761) | Trials (npc 17761) | Recent Studies (post-2010) (npc 17761) | Studies (arg-3-hyp-7-phe-bradykinin) | Trials (arg-3-hyp-7-phe-bradykinin) | Recent Studies (post-2010) (arg-3-hyp-7-phe-bradykinin) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 52 | 2 | 3 |
| Protein | Taxonomy | npc 17761 (IC50) | arg-3-hyp-7-phe-bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0113 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WM; Burch, R; Forteza, R; Lauredo, IT | 1 |
1 other study(ies) available for npc 17761 and arg-3-hyp-7-phe-bradykinin
| Article | Year |
|---|---|
Extracellular metabolites of Pseudomonas aeruginosa produce bronchoconstriction by different mechanisms.
Topics: Administration, Inhalation; Aerosols; Airway Resistance; Animals; Atropine; Bradykinin; Bradykinin Receptor Antagonists; Bronchial Diseases; Bronchoalveolar Lavage Fluid; Chlorpheniramine; Constriction, Pathologic; Drug Evaluation, Preclinical; Endotoxins; Female; Inflammation; Kinins; Nedocromil; Phenazines; Premedication; Pseudomonas aeruginosa; Pyocyanine; Sheep | 1994 |